Guardian Pharmacy Services, Inc.

GRDN

Guardian Pharmacy Services, Inc.

GRDN

Insider Sentiment (TTM):

Last Purchase:2025-12-03Last Sale:2026-03-20Shares Purchased (TTM):3,370Shares Sold (TTM):14,124,718

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:26,690,693Shares Outstanding:63,321,000Institutional Ownership Pct.:42.15%

Earnings Market Reaction:

Filing Date:2026-05-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Retail-Drug Stores and Proprietary Stores

CVS PETS CANN AIXN

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	65	66	36	19	14	37
Accounts Receivable Net Current	112	102	106	94	97	91
Inventory Net	47	43	48	44	43	45
Other Assets Current	11	11	8	13	11	7
Assets Current	235	222	198	170	166	180
Property Plant And Equipment Net	57	56	56	54	51	48
Intangible Assets Net Excluding Goodwill	17	18	19	18	14	15
Goodwill	80	80	80	76	69	68
Operating Lease Right Of Use Asset	34	35	32	32	27	30
Deferred Income Tax Assets Net	2	2	5	5	5	6
Other Assets Noncurrent	1	0	0	0	0	0
Assets	427	413	390	356	334	348
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	109	116	122	105	102	107
Employee Related Liabilities Current	13	15	16	17	10	14
Lines Of Credit Current	-	-	-	-	-	10
Notes Payable Current	-	-	-	-	-	5
Operating Lease Liability Current	7	7	7	7	7	7
Other Liabilities Current	32	22	18	15	26	15
Liabilities Current	161	161	162	144	145	158
Long Term Notes Payable	-	-	-	-	-	29
Operating Lease Liability Noncurrent	30	30	27	27	22	24
Other Liabilities Noncurrent	4	4	5	6	4	3
Liabilities	195	195	195	177	171	214
Stockholders Equity
Members Capital	-	0	-	-	-	-
Additional Paid In Capital	141	139	138	134	129	122
Retained Earnings Accumulated Deficit	80	66	45	36	27	5
Minority Interest	12	12	12	10	7	6
Stockholders Equity	232	218	195	180	163	134
Liabilities And Stockholders Equity	427	413	390	356	334	348

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	5.90%	15.66%	10.58%	-	-	-	-	-	-	-	-	-
2025	-19.52%	-18.75%	-20.77%	41.90%	20.42%	41.05%	0.03%	-0.74%	1.51%	13.37%	11.52%	15.61%
2024	-	-	-	-	-	-	12.71%	-10.78%	2.84%	-	-	-
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Liquidity Ratios
Current Ratio	1.46	1.38	1.22	1.18	1.14	1.14
Quick Ratio	1.17	1.11	0.93	0.88	0.84	0.85
Working Capital	74.64M	60.93M	36.33M	26.47M	20.75M	21.95M
Leverage & Debt
Debt to Equity	0.84	0.89	1.00	0.98	1.05	1.60
Interest Coverage TTM	119.22	109.32	-41.02	-	-	-
Debt Ratio	0.46	0.47	0.50	0.50	0.51	0.62
Efficiency & Turnover
Asset Turnover TTM	3.83	3.81	3.50	-	-	-
Days Sales Outstanding TTM	26.21	24.26	28.38	-	-	-
Receivables Turnover TTM	13.93	15.05	12.86	-	-	-
Per Share Metrics
Diluted EPS TTM	0.83	0.77	-1.23	-	-	-
Free Cash Flow Per Share TTM	1.19	1.39	1.22	-	-	-
Dividend Per Share TTM	0.00	0.00	0.00	-	-	-
Margin Metrics
Gross Profit Margin TTM	20.93%	20.21%	19.63%	-	-	-
Operating Profit Margin TTM	5.31%	5.02%	-4.59%	-	-	-
Net Profit Margin TTM	3.64%	3.38%	-5.69%	-	-	-
Valuation Metrics
P/E TTM	44.95	38.34	-20.96	-	-	-
P/B TTM	10.26	8.61	8.34	7.36	8.08	7.67
P/S TTM	1.64	1.30	1.19	-	-	-
Market Cap	2.38B	1.88B	1.63B	1.32B	1.32B	1.03B
Enterprise Value	2.32B	1.88B	1.59B	1.30B	1.31B	1.03B
Calculated Values
Free Cash Flow TTM	75.35M	86.84M	75.90M	-	-	-
Net Debt	-64.89M	3.68M	-36.49M	-18.82M	-14.00M	6.88M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-03-20Sale

Owner: Salentine, Thomas J Jr

Title: -

Shares: 3,570,677

Price/Share: $29.68

Value: $105,977,693.36

Shares Owned: 4,469,316

Relationship: Director,TenPercentOwner

Ownership: Indirect

2026-03-20Sale

Owner: Pharmacy, Investors, Llc

Title: -

Shares: 827,636

Price/Share: $29.68

Value: $24,564,236.48

Shares Owned: 1,035,928

Relationship: Other

Ownership: Direct

2026-03-20Sale

Owner: Cardinal, Equity Fund, L.…

Title: -

Shares: 275,728

Price/Share: $29.68

Value: $8,183,607.04

Shares Owned: 345,123

Relationship: Other

Ownership: Direct

2026-03-20Sale

Owner: Ackerman, John

Title: -

Shares: 1,103,364

Price/Share: $29.68

Value: $32,747,843.52

Shares Owned: 345,123

Relationship: Director

Ownership: Indirect

2026-03-20Sale

Owner: Bindley, Capital Partners…

Title: -

Shares: 3,570,677

Price/Share: $29.68

Value: $105,977,693.36

Shares Owned: 4,469,316

Relationship: TenPercentOwner

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-03-20	Salentine, Thomas J Jr	Director,TenPercentOwner	-	Indirect	Sale	3,570,677	29.68	$105,977,693.36	4,469,316	4
2026-03-20	Pharmacy, Investors, Llc	Other	-	Direct	Sale	827,636	29.68	$24,564,236.48	1,035,928	4
2026-03-20	Cardinal, Equity Fund, L.…	Other	-	Direct	Sale	275,728	29.68	$8,183,607.04	345,123	4
2026-03-20	Ackerman, John	Director	-	Indirect	Sale	1,103,364	29.68	$32,747,843.52	345,123	4
2026-03-20	Bindley, Capital Partners…	TenPercentOwner	-	Direct	Sale	3,570,677	29.68	$105,977,693.36	4,469,316	4
2026-03-20	Morris, David K	Director,Officer	See Remarks	Direct	Sale	187,855	29.68	$5,575,536.40	254,472	4
2026-03-20	Forbes, Kendall	Officer	See Remarks	Direct	Sale	346,672	29.68	$10,289,224.96	453,256	4
2026-03-20	Burke, Fred	Director,Officer	See Remarks	Direct	Sale	671,432	29.68	$19,928,101.76	840,413	4
2026-03-20	Bindley, William E	Director,TenPercentOwner	-	Indirect	Sale	3,570,677	29.68	$105,977,693.36	4,469,316	4
2025-12-03	Cosler, Steven D	Director	-	Direct	Purchase	3,370	29.61	$99,785.70	24,984	4
2025-05-28	Ackerman, John	Director	-	Indirect	Sale	201,303	20.16	$4,058,268.48	149,794	4
2025-05-28	Bindley, Capital Partners…	TenPercentOwner	-	Direct	Sale	651,454	20.16	$13,133,312.64	1,939,817	4
2025-05-28	Bindley, William E	Director,TenPercentOwner	-	Indirect	Sale	651,454	20.16	$13,133,312.64	1,939,817	4
2025-05-28	Cardinal, Equity Fund, L.…	Other	-	Direct	Sale	50,305	20.16	$1,014,148.80	149,794	4
2025-05-28	Pharmacy, Investors, Llc	Other	-	Direct	Sale	150,998	20.16	$3,044,119.68	449,624	4
2025-05-28	Forbes, Kendall	Officer	See Remarks	Direct	Sale	64,991	20.16	$1,310,218.56	203,906	4
2025-05-28	Burke, Fred	Director,Officer	See Remarks	Direct	Sale	138,705	20.16	$2,796,292.80	413,019	4
2025-05-28	Morris, David K	Director,Officer	See Remarks	Direct	Sale	68,547	20.16	$1,381,907.52	214,495	4
2025-05-28	Salentine, Thomas J Jr	Director,TenPercentOwner	-	Indirect	Sale	651,454	20.16	$13,133,312.64	1,939,817	4
2024-11-19	Cosler, Steven D	Director	-	Direct	Purchase	7,000	21.22	$148,540.00	17,713	4
2024-09-27	Lewis, Randall J	Director	-	Direct	Purchase	3,571	14.00	$49,994.00	3,571	4
2024-09-27	Salentine, Thomas J Jr	Director	-	Direct	Purchase	35,714	14.00	$499,996.00	35,714	4
2024-09-27	Cosler, Steven D	Director	-	Direct	Purchase	7,142	14.00	$99,988.00	7,142	4
2024-09-27	Patchett, Mary Sue	Director	-	Direct	Purchase	3,571	14.00	$49,994.00	3,571	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

42.15%

Inst. Shares: 26,690,693

Shares Outstanding: 63,321,000

2025-12-31

31.47%

Inst. Shares: 19,633,160

Shares Outstanding: 62,386,253

2025-09-30

31.40%

Inst. Shares: 19,509,392

Shares Outstanding: 62,124,010

2025-06-30

28.04%

Inst. Shares: 17,398,784

Shares Outstanding: 62,045,901

2025-03-31

29.65%

Inst. Shares: 18,396,272

Shares Outstanding: 62,043,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	26,690,693	63,321,000	42.15%
2025-12-31	19,633,160	62,386,253	31.47%
2025-09-30	19,509,392	62,124,010	31.40%
2025-06-30	17,398,784	62,045,901	28.04%
2025-03-31	18,396,272	62,043,000	29.65%
2024-12-31	18,208,472	62,043,000	29.35%
2024-09-30	15,849,952	61,143,311	25.92%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Guardian Pharmacy Services, Inc. (GRDN) — SEC Financial Statements & Analysis

Guardian Pharmacy Services, Inc. (GRDN) is a retail-drug stores and proprietary stores company, incorporated in GA. Guardian Pharmacy Services, Inc. trades on GRDN: NYSE as: GRDN. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Guardian Pharmacy Services, Inc. reported a Gross Profit Margin of 20.93% (TTM), a Debt-to-Equity ratio of 0.84x, a Price-to-Sales (P/S) ratio of 1.64x (TTM), a Price-to-Book (P/B) ratio of 10.26 (TTM), at a market cap of $2.38B. Figures below are sourced from SEC EDGAR, as-filed.

Gross Profit Margin TTM: 20.93%
Debt To Equity: 0.84x
P/S TTM: 1.64x
P/B TTM: 10.26
Market Cap: $2.38B

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Guardian Pharmacy Services, Inc. in?

Guardian Pharmacy Services, Inc. (GRDN) operates in the Retail-Drug Stores and Proprietary Stores industry.

What is GRDN's market cap?

Guardian Pharmacy Services, Inc. (GRDN) has a market capitalization of $2.38B as of 2026-03-31.

What is GRDN's P/E ratio?

Guardian Pharmacy Services, Inc. (GRDN)'s trailing twelve month P/E ratio is 44.95x as of 2026-03-31.

What exchange does GRDN trade on?

Guardian Pharmacy Services, Inc. (GRDN) trades on the GRDN: NYSE.

Where is Guardian Pharmacy Services, Inc. incorporated?

Guardian Pharmacy Services, Inc. is incorporated in GA.

Guardian Pharmacy Services, Inc. (GRDN) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.